Conmed CNMD
NYSE CNMD
$46.99 +0.40 (+0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Conmed (CNMD) Gross Profit Growth (3y) (2013 - 2026)

Analysis

Conmed (CNMD) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 9.77%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 18.71%
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 7.71%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 12.24%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 14.82%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 9.36%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 7.11%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 14.95%
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 8.95%
10 Conmed 1.48 Bn 1.44 Bn 197.46 Mn 4.98%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.98%
Mar 31, 2026 5.70%
Dec 31, 2025 18.30%
Sep 30, 2025 3.09%
Jun 30, 2025 7.46%
Mar 31, 2025 9.34%
Dec 31, 2024 8.37%
Sep 30, 2024 7.95%
Jun 30, 2024 9.12%
Mar 31, 2024 10.21%
Dec 31, 2023 10.37%
Sep 30, 2023 7.92%
Jun 30, 2023 33.38%
Mar 31, 2023 9.24%
Dec 31, 2022 -2.43%
Sep 30, 2022 5.23%
Jun 30, 2022 4.98%
Mar 31, 2022 3.84%
Dec 31, 2021 5.52%
Sep 30, 2021 8.76%